Teen Pregnancy Linked to Future Premature Mortality
By Elana Gotkine HealthDay Reporter
FRIDAY, March 15, 2024 -- Teen pregnancy is associated with future premature mortality, according to a study published online March 14 in JAMA Network Open.
Joel G. Ray, M.D., from the University of Toronto, and colleagues examined the risk of premature mortality from age 12 onward in association with teen pregnancies in a population-based cohort study involving all females alive at age 12 from April 1, 1991, to March 31, 2021, in Ontario, Canada.
Overall, 7.3 percent of the 2,242,929 teenagers experienced a pregnancy at a median age of 18 years. The researchers found that 36.8 percent of those with a teen pregnancy ended in a birth (99.1 percent live births) and 65.1 percent ended in induced abortion. The median age at the end of follow-up was 25 and 31 years for those without and with a teen pregnancy, respectively. Among those without, with one, and with two or more teen pregnancies, there were 6,030; 701; and 345 deaths, respectively (1.9, 4.1, and 6.1 per 10,000 person-years), with adjusted hazard ratios of 1.51 and 2.14 for those with one and two or more pregnancies, respectively. The adjusted hazard ratio for premature death was 1.25, 2.06, and 2.02 from noninjury, from unintentional injury, and from intentional injury, respectively, comparing those with versus without a teen pregnancy.
"This cohort study suggests that teen pregnancy may be a readily identifiable marker for subsequent risk of premature mortality in early adulthood," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.